Page last updated: 2024-08-23

phosphotyrosine and beta-Thalassemia

phosphotyrosine has been researched along with beta-Thalassemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
An, R; Gurkan, UA; Kalfa, T; Little, JA; Low, PS; Man, Y; Noomuna, P; Risinger, M; Seu, K; Sheik, DA; Turrini, FM; Wan, J; Zhou, S	1
Carvalho, CR; Costa, FF; Saad, MJ; Saad, ST; Terra, HT; Vicentin, DL	1

Other Studies

2 other study(ies) available for phosphotyrosine and beta-Thalassemia

Article	Year
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. British journal of haematology, 2020, Volume: 190, Issue:4 Topics: Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; beta-Thalassemia; Cell Adhesion; Cell-Derived Microparticles; Drug Evaluation, Preclinical; Endothelium, Vascular; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes, Abnormal; Hemoglobin, Sickle; Humans; Imatinib Mesylate; Oxidative Stress; Oxygen; Phosphorylation; Phosphotyrosine; Plasma; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Sickle Cell Trait	2020
Increased tyrosine phosphorylation of band 3 in hemoglobinopathies. American journal of hematology, 1998, Volume: 58, Issue:3 Topics: Adolescent; Adult; Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; Antibodies; beta-Thalassemia; Erythrocyte Count; Erythrocytes; Hemoglobin SC Disease; Hemoglobinopathies; Humans; Immunoblotting; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Reticulocytes; Tyrosine; Vanadates	1998

Article

Year

Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.

British journal of haematology, 2020, Volume: 190, Issue:4

Topics: Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; beta-Thalassemia; Cell Adhesion; Cell-Derived Microparticles; Drug Evaluation, Preclinical; Endothelium, Vascular; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes, Abnormal; Hemoglobin, Sickle; Humans; Imatinib Mesylate; Oxidative Stress; Oxygen; Phosphorylation; Phosphotyrosine; Plasma; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Sickle Cell Trait

2020

Increased tyrosine phosphorylation of band 3 in hemoglobinopathies.

American journal of hematology, 1998, Volume: 58, Issue:3

Topics: Adolescent; Adult; Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; Antibodies; beta-Thalassemia; Erythrocyte Count; Erythrocytes; Hemoglobin SC Disease; Hemoglobinopathies; Humans; Immunoblotting; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Reticulocytes; Tyrosine; Vanadates

1998